Patient presents with signs and symptoms suggestive of Vancomycin-Resistant Enterococcus (VRE) infection.  Clinical presentation includes [specific symptoms e.g., fever, urinary urgency, frequency, dysuria, wound infection, abdominal pain].  Patient history includes [relevant risk factors e.g., recent hospitalization, prolonged antibiotic use, indwelling catheters, compromised immune system, underlying medical conditions].  Laboratory testing ordered includes urine culture, blood culture, wound culture as indicated by presenting symptoms.  Preliminary results indicate [preliminary lab findings if available e.g., gram-positive cocci in clusters].  Differential diagnoses considered include other multi-drug resistant organisms, urinary tract infection (UTI), bloodstream infection (BSI), surgical site infection (SSI), and other infections based on the clinical presentation.  VRE colonization versus infection is being evaluated.  Infection prevention protocols, including contact precautions, have been initiated.  Pending definitive VRE confirmation via culture and sensitivity testing, empiric antibiotic therapy with [mention specific antibiotic e.g., linezolid, daptomycin] has been initiated, considering the suspected VRE infection and patient's current clinical status.  Patient education provided on VRE, including transmission prevention, hand hygiene, and medication adherence.  Plan to adjust antibiotic therapy based on final culture and sensitivity results.  Further evaluation and management will be determined based on the patient's response to therapy and evolving clinical picture. Ongoing monitoring for complications, including sepsis, acute kidney injury, and endocarditis, will be performed. ICD-10 code [appropriate code e.g., A49.02 for VRE UTI] will be finalized upon confirmation of diagnosis.  CPT codes for performed and planned procedures will be documented accordingly.